{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:03:53Z","timestamp":1790694233175,"version":"4.1.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z1AHD008735"],"award-info":[{"award-number":["Z1AHD008735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00515","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:34:41Z","timestamp":1543278881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging"],"prefix":"10.3389","volume":"9","author":[{"given":"Rami","family":"Alrezk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","first-page":"179","article-title":"Tumours of the adrenal medulla and extra-adrenal paraganglia","volume-title":"WHO Classification of Tumours of Endocrine Organs 4th Edition","author":"Tischler","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","article-title":"Extra-adrenal pheochromocytoma","volume":"147","author":"Whalen","year":"1992","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01607135","article-title":"Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma","volume":"421","author":"Kimura","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"B4","first-page":"107","article-title":"Metachronous bilateral nonfunctional intercarotid paraganglioma (carotid body tumor) and functional retroperitoneal paraganglioma: report of a case and review of the literature","volume":"114","author":"Mena","year":"1993","journal-title":"Surgery"},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1210\/jc.2009-1632","article-title":"Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas","volume":"95","author":"van","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","article-title":"Genomic landscape of pheochromocytoma and paraganglioma","volume":"4","author":"Jochmanova","year":"2018","journal-title":"Trends Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Crona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cancergen.2016.04.058","article-title":"ATRX driver mutation in a composite malignant pheochromocytoma","volume":"209","author":"Comino-M\u00e9ndez","year":"2016","journal-title":"Cancer Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-17-3406","article-title":"Targeting NAD(+)\/PARP DNA repair pathway as a novel therapeutic approach to SDHB-mutated cluster i pheochromocytoma and paraganglioma","volume":"24","author":"Pang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1210\/jc.2009-1156","article-title":"Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors","volume":"94","author":"Carney","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome","volume":"99","author":"Buffet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","article-title":"Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas","volume":"24","author":"Castelblanco","year":"2013","journal-title":"Endocr Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1210\/jc.2014-1870","article-title":"SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma\/paraganglioma","volume":"100","author":"Menara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/apm.12269","article-title":"Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes","volume":"122","author":"Pai","year":"2014","journal-title":"APMIS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.21873\/anticanres.11381","article-title":"Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation","volume":"37","author":"Santi","year":"2017","journal-title":"Anticancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision medicine: an update on genotype\/biochemical phenotype relationships in pheochromocytoma\/paraganglioma patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/blood-2012-10-460972","article-title":"Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas","volume":"121","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1126\/science.2833817","article-title":"Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain","volume":"240","author":"Adari","year":"1988","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12885-018-4127-x","article-title":"A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2(V617F) positive polycythemia vera: a case report","volume":"18","author":"Pang","year":"2018","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","author":"Lorenzo","year":"2013","journal-title":"J Mol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/ERC-16-0231","article-title":"Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome","volume":"23","author":"D\u00e4rr","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.ophtha.2014.06.019","article-title":"Ocular manifestations of hypoxia-inducible factor-2alpha paraganglioma-somatostatinoma-polycythemia syndrome","volume":"121","author":"Pacak","year":"2014","journal-title":"Ophthalmology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/bies.200900122","article-title":"Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression","volume":"32","author":"Mihailovich","year":"2010","journal-title":"BioEssays"},{"key":"B40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2013.08.055","article-title":"The control of precerebellar neuron migration by RNA-binding protein Csde1","volume":"253","author":"Kobayashi","year":"2013","journal-title":"Neuroscience"},{"key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discovery"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1038\/sj.onc.1210068","article-title":"Unr, a cytoplasmic RNA-binding protein with cold-shock domains, is involved in control of apoptosis in ES and HuH7 cells","volume":"26","author":"Dormoy-Raclet","year":"2007","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/stem.712","article-title":"The RNA-binding protein Unr prevents mouse embryonic stem cells differentiation toward the primitive endoderm lineage","volume":"29","author":"Elatmani","year":"2011","journal-title":"Stem Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.yexcr.2003.09.007","article-title":"Altered notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors","volume":"292","author":"Enlund","year":"2004","journal-title":"Exp Cell Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"E3260","DOI":"10.1073\/pnas.1319176111","article-title":"CRTC1\/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement","volume":"111","author":"Amelio","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1093\/nar\/gkq622","article-title":"MapSplice: accurate mapping of RNA-seq reads for splice junction discovery","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/dvdy.22213","article-title":"Med24 and Mdh2 are required for Drosophila larval salivary gland cell death","volume":"239","author":"Wang","year":"2010","journal-title":"Dev Dyn."},{"key":"B48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1126\/science.1103786","article-title":"Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo","volume":"306","author":"Meyron-Holtz","year":"2004","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood-2013-03-492454","article-title":"IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2alpha mRNA translation","volume":"122","author":"Wilkinson","year":"2013","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/nar\/15.7.2871","article-title":"Unusual structure, evolutionary conservation of non-coding sequences and numerous pseudogenes characterize the human H3","volume":"15","author":"Wells","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"B54","first-page":"1119","article-title":"Principles of biochemistry","author":"Lehninger","year":"2004"},{"key":"B55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.2106\/JBJS.CC.L.00155","article-title":"Multicentric giant cell tumor of bone and paraganglioma: a case report","volume":"3","author":"Iwata","year":"2013","journal-title":"JBJS Case Connect"},{"key":"B59","doi-asserted-by":"publisher","first-page":"14344","DOI":"10.1073\/pnas.0507200102","article-title":"Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas","volume":"102","author":"Rand","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.gde.2013.01.005","article-title":"ATRX and the replication of structured DNA","volume":"23","author":"Clynes","year":"2013","journal-title":"Curr Opinion Genet Dev"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1093\/nar\/gku564","article-title":"Analysis of neonatal brain lacking ATRX or MeCP2 reveals changes in nucleosome density, CTCF binding and chromatin looping","volume":"42","author":"Kernohan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/epi.23271","article-title":"ATRX: the case of a peculiar chromatin remodeler","volume":"8","author":"Ratnakumar","year":"2013","journal-title":"Epigenetics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","article-title":"Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations","volume":"124","author":"Liu","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/hed.10068","article-title":"Combined endovascular and surgical treatment of head and neck paragangliomas\u2013a team approach","volume":"24","author":"Persky","year":"2002","journal-title":"Head Neck"},{"key":"B66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines","volume":"51","author":"Eisenhofer","year":"2005","journal-title":"Clin Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/eje.0.1470085","article-title":"The value of plasma markers for the clinical behaviour of phaeochromocytomas","volume":"147","author":"van","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4149\/endo_2011_02_65","article-title":"Phaeochromocytoma: a catecholamine and oxidative stress disorder","volume":"45","author":"Pacak","year":"2011","journal-title":"Endocr Regul"},{"key":"B69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1196\/annals.1353.026","article-title":"Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2","volume":"1073","author":"Huynh","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.yexcr.2004.10.003","article-title":"HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia","volume":"303","author":"Nilsson","year":"2005","journal-title":"Exp Cell Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/ncpendmet0615","article-title":"An assessment of biochemical tests for the diagnosis of pheochromocytoma","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B74","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02067379","article-title":"The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma","volume":"16","author":"Ito","year":"1992","journal-title":"World J Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.14310\/horm.2002.1227","article-title":"Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome","volume":"8","author":"Pacak","year":"2009","journal-title":"Hormones"},{"key":"B76","first-page":"5153","article-title":"Dopamine excess in patients with head and neck paragangliomas","volume":"30","author":"Van","year":"2010","journal-title":"Anticancer Res"},{"key":"B77","first-page":"103","article-title":"[Malignant carotid paraganglioma. A case report]","volume":"120","author":"Righini","year":"2003","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"key":"B78","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1530\/EJE-13-0529","article-title":"Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites","volume":"169","author":"van","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06902-9","article-title":"Cardiovascular and renal actions of dopamine: potential clinical applications","volume":"24","author":"Goldberg","year":"1972","journal-title":"Pharmacol Rev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1006\/jsre.1993.1094","article-title":"Identification of dopamine1A receptors in the rat small intestine","volume":"54","author":"Marmon","year":"1993","journal-title":"J Surg Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0033-3182(89)72333-1","article-title":"Vomiting, chemoreceptor trigger zone, and dopamine","volume":"30","author":"Shen","year":"1989","journal-title":"Psychosomatics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clin Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review","volume":"56","author":"D\u00e4rr","year":"2017","journal-title":"Endocrine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jcem.87.5.8446","article-title":"Utility of plasma free metanephrines for detecting childhood pheochromocytoma","volume":"87","author":"Weise","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.trac.2016.01.027","article-title":"Impact of LC-MS\/MS on the laboratory diagnosis of catecholamine-producing tumors","volume":"84","author":"Eisenhofer","year":"2016","journal-title":"TrAC Trends in Anal Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/jc.2003-031091","article-title":"Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma","volume":"89","author":"Ilias","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2796.2004.01425.x","article-title":"Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour","volume":"257","author":"Pacak","year":"2005","journal-title":"J Intern Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2967\/jnumed.117.192674","article-title":"The Evolving Role of Succinate in Tumor Metabolism: An (18)F-FDG-Based Study","volume":"58","author":"Garrigue","year":"2017","journal-title":"J Nucl Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2967\/jnumed.117.189688","article-title":"PET Imaging for endocrine malignancies: from woe to go","volume":"58","author":"Taieb","year":"2017","journal-title":"J Nucl Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/bjs.6937","article-title":"Value of combined 6-[18F]fluorodihydroxyphenylalanine PET\/CT for imaging of neuroendocrine tumours","volume":"97","author":"Schiesser","year":"2010","journal-title":"Br J Surg"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/1097-0142(19901115)66:10<2129::AID-CNCR2820661015>3.0.CO;2-T","article-title":"Identification of somatostatin receptors in human small cell lung carcinoma","volume":"66","author":"Sagman","year":"1990","journal-title":"Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B96","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J Nucl Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.2967\/jnumed.116.187690","article-title":"Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes","volume":"58","author":"Janssen","year":"2017","journal-title":"J Nucl Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.4158\/EP15759.CR","article-title":"Functional imaging experience in a germline fumarate hydratase mutation-positive a patient with pheochromocytoma and paraganglioma","volume":"2","author":"Nambuba","year":"2016","journal-title":"AACE Clin Case Rep Summer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/jc.2017-02324","article-title":"18F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma","volume":"103","author":"Ta\u00efeb","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B100","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of (68)Ga-DOTATATE over (18)F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B101","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","article-title":"Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors","volume":"161","author":"Babic","year":"2017","journal-title":"Surgery"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa1607427","article-title":"177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0032-1311637","article-title":"Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)","volume":"44","author":"Zovato","year":"2012","journal-title":"Horm Metab Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00259-015-3029-2","article-title":"Peptide receptor radionuclide therapy with (90)Y\/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)","volume":"42","author":"Puranik","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1210\/jc.2017-00816","article-title":"Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) for Functional Metastatic Paraganglioma and Phaeochromocytoma","volume":"102","author":"Kong","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B106","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jso.24553","article-title":"Peptide receptor radionuclide treatment and (131)I-MIBG in the management of patients with metastatic\/progressive phaeochromocytomas and paragangliomas","volume":"115","author":"Nastos","year":"2017","journal-title":"J Surg Oncol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"16436","DOI":"10.1073\/pnas.0607761103","article-title":"Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors","volume":"103","author":"Ginj","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B108","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2967\/jnumed.112.102764","article-title":"Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications","volume":"53","author":"Fani","year":"2012","journal-title":"J Nucl Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2967\/jnumed.115.167007","article-title":"Comparison of the therapeutic response to treatment with a 177Lu-labeled somatostatin receptor agonist and antagonist in preclinical models","volume":"57","author":"Dalm","year":"2016","journal-title":"J Nucl Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2967\/jnumed.117.191684","article-title":"Biodistribution, pharmacokinetics, and dosimetry of (177)Lu-, (90)Y-, and (111)In-labeled somatostatin receptor antagonist OPS201 in comparison to the agonist (177)Lu-dotatate: the mass effect","volume":"58","author":"Nicolas","year":"2017","journal-title":"J Nucl Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2967\/jnumed.116.177733","article-title":"Highly increased 125I-JR11 antagonist binding in vitro reveals novel indications for sst2 targeting in human cancers","volume":"58","author":"Reubi","year":"2017","journal-title":"J Nucl Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00515\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:05:58Z","timestamp":1775282758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00515\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":112,"alternative-id":["10.3389\/fendo.2018.00515"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00515","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"515"}}